Registry for patients with congenital heart disease
Official title: Invasive Hemodynamic Control Cohort for The Mayo Clinic Adult Congenital Heart Disease (MACHD) Registry
Run by Mayo Clinic · NCT05849025 · Data updated 2026-11-12
This study is gathering information from adults with congenital heart disease to better understand their health and improve care for them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | October 16, 2023 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT05849025 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with congenital heart disease who meet specific health criteria and can undergo an MRI.
✕Probably not a fit
Patients with a history of cardiovascular disease or those currently taking cardiac medication may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather comparative data for the Mayo Clinic Adult Congenital Heart Disease Registry. It will involve patients who meet specific health criteria, including those with a BMI of 30 or less and stable blood pressure levels. Participants will undergo assessments to ensure they can consent and meet kidney function requirements. The study will help enhance understanding of congenital heart disease in adults.
Why it matters
Potential benefit: If successful, this study could improve the management and treatment strategies for adults with congenital heart disease.
How similar studies have gone: Other studies have shown success in utilizing registries for congenital heart disease, indicating this approach is supported by prior research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Capacity to Consent * BMI \</= 30 * Systolic BP \</= 140mmHg * Diastolic BP \</= 90 * eGFR \> 30 (within prior 3 months) to confirm kidney function * Able to undergo an MRI Exclusion Criteria: * History of Cardiovascular disease that may affect the results of the testing performed. * Any Current orthopedic limitations * Currently taking any cardiac medication * Pregnancy
Where it's running
-
Mayo Clinic Rochester
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Alexander Egbe, MBBS, MPH — Mayo Clinic
- Study coordinator: ACHD Research Program
- Phone: (507) 293-2565
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Prehabilitation before heart surgery for adults with congenital heart disease
This study is testing whether a tailored, supervised exercise program before heart surgery helps adults with congenital heart disease perform better and improve fitness.
-
Accessible care model comparing nurse-led versus physician-led transition education for teens and young adults with congenital heart disease
This project will test whether an accessible care model and nurse-led versus physician-led transition education helps teens and young adults (ages 12–26) with congenital heart disease move successfully from pediatric to adult heart care.
-
Surgical techniques and outcomes across the lifespan in congenital heart disease in China
See which surgical factors and care patterns affect recovery after heart surgery for people with complex congenital heart disease in China.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.